Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KH-CB19 is an effective and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4).
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 1,590 | 5日内发货 | ||
5 mg | 待询 | 5日内发货 | ||
25 mg | 待询 | 6-8周 | ||
50 mg | 待询 | 6-8周 | ||
100 mg | 待询 | 6-8周 | ||
1 mL * 10 mM (in DMSO) | 待询 | 5日内发货 |
产品描述 | KH-CB19 is an effective and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4). |
靶点活性 | CLK1:19.7 nM, DYRK1A:55.2 nM, CLK3:530 nM |
体外活性 | KH-CB19 showed potent inhibition of CLK1 (IC50: 20 nM), and for the pure isomer KH-CB19, almost 100-fold selectivity against the CLK3 isoform. Treatment of resting cells with 10 μM KH-CB19 significantly reduced the basal expression of flTF as well as HTF. Pretreatment of cells with KH-CB19 or TG003 led to a reduction of the TNF-α-induced increase in phosphorylation of all analyzed SR proteins compared with TNF-α-stimulated controls [1]. |
分子量 | 338.19 |
分子式 | C15H13Cl2N3O2 |
CAS No. | 1354037-26-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (147.85 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.9569 mL | 14.7846 mL | 29.5692 mL | 73.9229 mL |
5 mM | 0.5914 mL | 2.9569 mL | 5.9138 mL | 14.7846 mL | |
10 mM | 0.2957 mL | 1.4785 mL | 2.9569 mL | 7.3923 mL | |
20 mM | 0.1478 mL | 0.7392 mL | 1.4785 mL | 3.6961 mL | |
50 mM | 0.0591 mL | 0.2957 mL | 0.5914 mL | 1.4785 mL | |
100 mM | 0.0296 mL | 0.1478 mL | 0.2957 mL | 0.7392 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
KH-CB19 1354037-26-5 Others KHCB19 KH CB19 KH-CB-19 Inhibitor inhibitor inhibit